Skip to Content

How is Cotempla XR-ODT different to other brands of methylphenidate?

Medically reviewed by Last updated on Sep 11, 2019.

Official Answer


Cotempla XR-ODT is the first once-daily, extended-release, orally disintegrating tablet (ODT) formulation of the stimulant methylphenidate.

This ODT form is designed to dissolve on the tongue without the need to swallow with water. 

Cotempla XR-ODT (methylphenidate) was approved in June 2017 for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age. It is not approved for use in adults.

Other brands of methylphenidate on the U.S market have various dosage forms.
For more information, see What are the brands of methylphenidate?

Related Medical Questions

Drug Information

Related Support Groups